Teduglutide granted orphan drug designation in Japan
NPS Pharmaceuticals announced the Japanese MHLW has granted teduglutide orphan drug designation for the treatment of Short Bowel Syndrome. Also, the MHLW's expert committee on Unapproved New Drugs requested that NPS Pharma Japan develop teduglutide for adult SBS earlier this year. November 24, 2014